Introducing new health interventions
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7533.64 (Published 12 January 2006) Cite this as: BMJ 2006;332:64- John Gabbay, emeritus professor (jg3@soton.ac.uk),
- Tom Walley, professor of clinical pharmacology
- Wessex Institute for Health Research and Development, University of Southampton, Southampton SO16 7PX
- Departmentt of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GF
Throughout the world, healthcare innovations have put pressure on limited resources while governments and patients have demanded top quality, yet cost effective, services. This makes it increasingly difficult for anyone who plans, provides, or receives health services to judge which intervention to use—what works, how well, at what cost, for whom, in what circumstances, and with what impact? Health technology assessment (HTA) is a multidisciplinary specialty whose purpose is to bring together the evidence to answer those questions.1 It boasts a thriving international scientific society (Health Technology Assessment International; www.htai.org) and a global network of more than 40 public sector agencies (International Network of Agencies for Health Technology Assessment; www.inahta.org). It evaluates the costs, effectiveness, and sometimes the wider impact of any intervention used in the care of patients, including medicines, devices, techniques, and skills. In the UK, for example, the HTA programme (www.ncchta.org) has produced more than 300 reports that have had an impact on services, including novel research as well as syntheses of evidence …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.